Preventing COPD exacerbations with macrolides: A review and budget impact analysis – Author response to letter to the Editor

Preventing COPD exacerbations with macrolides: A review and budget impact analysis – Author response to letter to the Editor

[...]although there are clear indications that long-term treatment of COPD patients with macrolides is cost-effective, a future economic evaluation needs to establish the health care setting and the type of COPD patients for which long-term treatment with macrolides is cost-effective.

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Respiratory medicine 2014-07, Vol.108 (7), p.1065-1065
Hauptverfasser: Simoens, Steven, Laekeman, Gert, Decramer, Marc
Format: Artikel
Sprache:eng
Schlagworte:
Ambulatory care
Anti-Bacterial Agents - therapeutic use
Budgets
Chronic obstructive pulmonary disease
Cost control
Drug therapy
Editors
Health Care Costs - statistics & numerical data
Humans
Macrolides - therapeutic use
Pulmonary Disease, Chronic Obstructive - prevention & control
Pulmonary/Respiratory
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:[...]although there are clear indications that long-term treatment of COPD patients with macrolides is cost-effective, a future economic evaluation needs to establish the health care setting and the type of COPD patients for which long-term treatment with macrolides is cost-effective.
ISSN:0954-6111
1532-3064
DOI:10.1016/j.rmed.2014.04.013